The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Vertex Pharmaceuticals Inc

Nasdaq: VRTX
Last

(U.S.) $117.80

Today's change0.00 0.00%
Updated May 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

Vertex Pharmaceuticals Inc

Nasdaq: VRTX
Last

(U.S.) $117.80

Today's change0.00 0.00%
Updated May 24 4:00 PM EDT. Delayed by at least 15 minutes.

Vertex Pharmaceuticals Inc closed at (U.S.)$117.80.

Over the last five days, shares have gained 2.99% and are currently 3.41% off of the 52-week high. Shares have outperformed the S&P 500 by 17.41% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $117.80
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change+59.90%
  • Volume0
  • Average volume (10-day)1,457,638
  • Average volume (1-month)1,649,857
  • Average volume (3-month)1,810,599
  • 52-week range(U.S.) $71.46 to (U.S.) $121.96
  • Beta1.66
  • Trailing P/E166.37×
  • P/E 1 year forward71.38×
  • Forward PEG1.10×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.71
Updated May 24 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue715459414432
Total other revenue--------
Total revenue715459414432
Gross profit668399361387
Total cost of revenue46605344
Total operating expense444419433428
Selling / general / administrative113110106112
Research & development274248272271
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)10000
Other operating expenses, total1111
Operating income27140-193
Interest income (expense), net non-operating-17------
Gain (loss) on sale of assets--------
Other--------
Income before tax25420-39-18
Income after tax25028-40-36
Income tax, total4-7118
Net income24833-39-65
Total adjustments to net income--------
Net income before extra. items24833-39-65
Minority interest-251-28
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items24833-39-65
Inc. avail. to common incl. extra. items24833-39-65
Diluted net income24833-39-65
Dilution adjustment--------
Diluted weighted average shares249245245244
Diluted EPS excluding extraordinary itemsvalue per share1.000.13-0.16-0.26
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.040.13-0.16-0.26